Tiamat Sciences is reinventing recombinant proteins to fuel the next generation of biotech companies across cellular agriculture, regenerative medicine, vaccine production, and more. Using the power of plants, Tiamat provides animal-free recombinant proteins at a fraction of their cost with a reduced carbon footprint. The team is on track to become a fast-growing supplier of recombinant proteins.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
03/09/23 | $2,000,000 | Seed Extension |
8090 Industries Alexandria Venture Investments Cantos Ventures Exponential Impact Portfolia Sara Murray Seed Folio Siddhi Capital Social Impact Capital Sustainable Food Ventures True Ventures | undisclosed |